BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16503549)

  • 41. [Study on mixed lineage leukemia gene rearrangement in AML-M4/M5 by interphase fluorescence in situ hybridization].
    Pan JL; Xue YQ; Jiang HY; Li JY; Chen SN; Wu YF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):288-90. PubMed ID: 15192841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.
    Park TS; Lee ST; Song J; Lee KA; Lee SG; Kim J; Suh B; Kim SJ; Lee JH; Park R; Choi JR
    Cancer Genet Cytogenet; 2008 Nov; 187(1):50-3. PubMed ID: 18992643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection and clinical features of MLL gene rearrangement in adult patients with acute leukemia].
    Liu P; Zhang R; Ge Z; Lin ZK; Liu J; Qian SX; Zhang SJ; Lu H; Wu HX; Qiu HX; Liu P; Xu W; Chen LJ; Lu C; Lu BB; Qiao C; Qiu HR; Zhu GR; Zhang JF; Wu YJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1110-6. PubMed ID: 23114129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation.
    Odero MD; Zeleznik-Le NJ; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2000 Dec; 29(4):333-8. PubMed ID: 11066077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
    Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MLL insertion with MLL-MLLT3 gene fusion in acute leukemia: case report and review of the literature.
    Soler G; Radford I; Meyer C; Marschalek R; Brouzes C; Ghez D; Romana S; Berger R
    Cancer Genet Cytogenet; 2008 May; 183(1):53-9. PubMed ID: 18474298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis.
    Giusiano S; Formisano-Tréziny C; Benziane A; Maroc N; Picard C; Hermitte F; Taranger-Charpin C; Gabert J
    Int J Lab Hematol; 2010 Aug; 32(4):398-409. PubMed ID: 19930410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
    Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
    Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MLL-AF9 rearrangement in myeloid sarcomas involving the breast.
    Wu B; Li F; Zou S
    Ann Hematol; 2014 Apr; 93(4):709-10. PubMed ID: 23900528
    [No Abstract]   [Full Text] [Related]  

  • 50. A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip device.
    Harrison CJ; Griffiths M; Moorman F; Schnittger S; Cayuela JM; Shurtleff S; Gottardi E; Mitterbauer G; Colomer D; Delabesse E; Castéras V; Maroc N
    Cancer Genet Cytogenet; 2007 Feb; 173(1):17-22. PubMed ID: 17284365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
    Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
    Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].
    Cabrera ME; Campbell M; Quintana J; Undurraga MS; Ford AA; Greaves MF
    Rev Med Chil; 2001 Jun; 129(6):634-42. PubMed ID: 11510203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
    Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
    Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
    Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
    Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangement.
    Klaus M; Schnittger S; Haferlach T; Dreyling M; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2003 Jul; 144(1):36-43. PubMed ID: 12810254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias.
    König M; Reichel M; Marschalek R; Haas OA; Strehl S
    Br J Haematol; 2002 Mar; 116(4):758-64. PubMed ID: 11886378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CASP8AP2 is a novel partner gene of MLL rearrangement with t(6;11)(q15;q23) in acute myeloid leukemia.
    Park TS; Lee SG; Song J; Lee KA; Kim J; Choi JR; Lee ST; Marschalek R; Meyer C
    Cancer Genet Cytogenet; 2009 Nov; 195(1):94-5. PubMed ID: 19837277
    [No Abstract]   [Full Text] [Related]  

  • 58. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes.
    Fleischmann KK; Pagel P; Schmid I; Roscher AA
    Mol Cancer; 2014 Feb; 13():27. PubMed ID: 24517546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.
    Hinterleitner C; Huelsenbeck J; Henninger C; Wartlick F; Schorr A; Kaina B; Fritz G
    Apoptosis; 2013 Aug; 18(8):963-79. PubMed ID: 23624644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
    Chin LK; Cheah CY; Michael PM; MacKinnon RN; Campbell LJ
    Leuk Lymphoma; 2012 Oct; 53(10):2066-8. PubMed ID: 22335556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.